Tetra Therapeutics: Grand Rapids-based Tetra Therapeutics finalizes deal to sell to Japanese partner

Grand Rapids biopharmaceutical company Tetra Therapeutics Inc. announced this week that it has a definitive agreement to sell to a Japanese firm in a deal that could reach $500 million, according to a statement.Tetra Therapeutics, which develops drugs for people suffering from Fragile X syndrome,...